Finasteride Tablet, Film Coated
Product Images NDC 67877-288

8 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 67877-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1)

Finasteride Figure 1 (Finasteride Fig.1)
A line graph showing the mean change from baseline with standard error over four years for Finasteride 5 mg oral tablets versus placebo. The y-axis represents mean change from baseline, and the x-axis represents time points at baseline and each year up to year 4. The graph shows greater improvement over time with Finasteride compared to placebo, with sample sizes labeled for each time point.*
FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

Finasteride-fig.2 (Finasteride Fig.2)
A line chart comparing the percentage of patients over a 48-month observation period between Finasteride and Placebo groups. The graph shows cumulative patient percentages on the y-axis and observation time in months on the x-axis. Data tables below the graph provide cumulative event counts and number of patients at risk per year for both Placebo and Finasteride groups.*
FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3)

Finasteride Figure 2 (Finasteride Fig.3)
A line graph comparing the mean percent change from baseline plus one standard error over four years between two groups: Placebo and Finasteride. The x-axis shows time points from baseline to year 4, with sample sizes for each group displayed below. The y-axis indicates percent change, ranging from -20 to 20. Placebo group data points increase positively over time, while Finasteride group data points decline negatively and stabilize after year 1.*
FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4)

Finasteride Figure 4 (Finasteride Fig.4)
A line graph displaying the percent of participants with an event over 5.5 years from randomization. Four treatment groups are shown: Placebo, Finasteride, Doxazosin, and Combination, with Placebo having the highest event rate and Combination the lowest across the timeline.*
FDA Label Image

Structutre (Finasteride Structure)

Structutre (Finasteride Structure)
Chemical structure diagram of Finasteride, the active ingredient in the product labeled as Finasteride 5 mg film-coated tablets by Ascend Laboratories, LLC.*
FDA Label Image

Fig 3finasteride

Fig 3finasteride
A line graph comparing the cumulative percent of patients over 48 months in two groups: Finasteride and Placebo. The x-axis shows observation time in months, and the y-axis shows percent of patients up to 15%. The graph includes tabular data listing the number of events and patients at risk per year for each group.*
FDA Label Image

Finasteride 10s Carton2

Finasteride 10s Carton2
Packaging label for Finasteride Tablets, USP 5 mg film-coated oral tablets by Ascend Laboratories, LLC. The carton contains 10 unit-dose tablets (1 x 10). The label includes warnings against use by women or children, storage instructions, manufacturer information (Alkem Laboratories Ltd., India), and distributor details (Ascend Laboratories, New Jersey).*
FDA Label Image

Finasteride-30 Counts (Finasteride 30)

Finasteride-30 Counts (Finasteride 30)
Label for Finasteride Tablets, USP 5 mg film-coated tablets, oral dosage form. The label indicates the product contains 30 tablets and is Rx only. It shows Ascend Laboratories, LLC as the distributor and Alkem Laboratories Ltd., Mumbai, India as the manufacturer. The label includes storage instructions and warnings specific to women and children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.